Definitive Healthcare Corp Stock Performance
| DH Stock | USD 4.66 0.02 0.43% |
Definitive Healthcare has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.81, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Definitive Healthcare will likely underperform. Definitive Healthcare right now shows a risk of 2.63%. Please confirm Definitive Healthcare maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to decide if Definitive Healthcare will be following its price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Definitive Healthcare Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong technical indicators, Definitive Healthcare is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
Actual Historical Performance (%)
One Day Return (0.43) | Five Day Return 10.43 | Year To Date Return (54.09) | Ten Year Return (89.24) | All Time Return (89.24) |
1 | Disposition of 14495 shares by William Moschella of Definitive Healthcare at 3.95 subject to Rule 16b-3 | 09/06/2024 |
2 | Disposition of 1044 shares by Shamsuddin Kate Marie of Definitive Healthcare at 4.44 subject to Rule 16b-3 | 09/13/2024 |
3 | Acquisition by Shamsuddin Kate Marie of 113379 shares of Definitive Healthcare subject to Rule 16b-3 | 09/27/2024 |
4 | Disposition of 2649 shares by Jason Krantz of Definitive Healthcare at 9.03 subject to Rule 16b-3 | 10/18/2024 |
5 | Definitive Healthcare Announces Timing of Its Third Quarter 2024 Financial Results Conference Call and Webcast | 10/24/2024 |
6 | Disposition of 7830 shares by Jason Krantz of Definitive Healthcare at 4.18 subject to Rule 16b-3 | 11/01/2024 |
7 | Acquisition by Richard Booth of 92379 shares of Definitive Healthcare subject to Rule 16b-3 | 11/05/2024 |
8 | Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024 | 11/07/2024 |
9 | Definitive Healthcare Corp Q3 2024 Earnings Call Highlights Navigating Revenue Challenges ... | 11/08/2024 |
10 | Definitive Healthcare Releases FY 2024 Earnings Guidance | 11/11/2024 |
11 | DH or PRVA Which Is the Better Value Stock Right Now - MSN | 11/20/2024 |
12 | Clark Estates Inc. NY Lowers Stock Position in Definitive Healthcare Corp. | 11/27/2024 |
| Begin Period Cash Flow | 146.9 M | |
| Free Cash Flow | 38.2 M |
Definitive |
Definitive Healthcare Relative Risk vs. Return Landscape
If you would invest 462.00 in Definitive Healthcare Corp on August 31, 2024 and sell it today you would earn a total of 4.00 from holding Definitive Healthcare Corp or generate 0.87% return on investment over 90 days. Definitive Healthcare Corp is generating 0.0476% of daily returns and assumes 2.6276% volatility on return distribution over the 90 days horizon. Put differently, 23% of stocks are less risky than Definitive on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Definitive Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Definitive Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Definitive Healthcare Corp, and traders can use it to determine the average amount a Definitive Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0181
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DH |
Estimated Market Risk
| 2.63 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Definitive Healthcare is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Definitive Healthcare by adding it to a well-diversified portfolio.
Definitive Healthcare Fundamentals Growth
Definitive Stock prices reflect investors' perceptions of the future prospects and financial health of Definitive Healthcare, and Definitive Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Definitive Stock performance.
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.0076 | ||||
| Profit Margin | (1.42) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 490.14 M | ||||
| Shares Outstanding | 115.52 M | ||||
| Price To Book | 1.06 X | ||||
| Price To Sales | 2.10 X | ||||
| Revenue | 251.41 M | ||||
| Gross Profit | 196.79 M | ||||
| EBITDA | (241.23 M) | ||||
| Net Income | (202.39 M) | ||||
| Cash And Equivalents | 347.87 M | ||||
| Cash Per Share | 3.46 X | ||||
| Total Debt | 267.93 M | ||||
| Debt To Equity | 0.19 % | ||||
| Current Ratio | 3.32 X | ||||
| Book Value Per Share | 4.39 X | ||||
| Cash Flow From Operations | 41.19 M | ||||
| Earnings Per Share | (3.09) X | ||||
| Market Capitalization | 538.34 M | ||||
| Total Asset | 1.83 B | ||||
| Retained Earnings | (227.45 M) | ||||
| Working Capital | 223.25 M | ||||
About Definitive Healthcare Performance
By evaluating Definitive Healthcare's fundamental ratios, stakeholders can gain valuable insights into Definitive Healthcare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Definitive Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Definitive Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 80.05 | 84.05 | |
| Return On Tangible Assets | (0.47) | (0.50) | |
| Return On Capital Employed | (0.20) | (0.19) | |
| Return On Assets | (0.11) | (0.11) | |
| Return On Equity | (0.23) | (0.22) |
Things to note about Definitive Healthcare performance evaluation
Checking the ongoing alerts about Definitive Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Definitive Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Definitive Healthcare has high likelihood to experience some financial distress in the next 2 years | |
| The company generated the yearly revenue of 251.41 M. Annual Net Loss to common stockholders was (202.39 M) with gross profit of 196.79 M. | |
| Over 95.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Clark Estates Inc. NY Lowers Stock Position in Definitive Healthcare Corp. |
- Analyzing Definitive Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Definitive Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Definitive Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Definitive Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Definitive Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Definitive Healthcare's stock. These opinions can provide insight into Definitive Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Definitive Stock analysis
When running Definitive Healthcare's price analysis, check to measure Definitive Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Definitive Healthcare is operating at the current time. Most of Definitive Healthcare's value examination focuses on studying past and present price action to predict the probability of Definitive Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Definitive Healthcare's price. Additionally, you may evaluate how the addition of Definitive Healthcare to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |